Opioid Induced Constipation (OIC) Drugs Market - Global Outlook and Forecast 2022-2028
Report Code: KNJ1156147 No. of Pages: 113 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Opioid Induced Constipation (OIC) Drugs in global, including the following market information:
Global Opioid Induced Constipation (OIC) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Opioid Induced Constipation (OIC) Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Opioid Induced Constipation (OIC) Drugs companies in 2021 (%)
The global Opioid Induced Constipation (OIC) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lubiprostone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioid Induced Constipation (OIC) Drugs include Ironwood Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co., Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma and S.L.A. Pharma AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Induced Constipation (OIC) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Induced Constipation (OIC) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation (OIC) Drugs Market Segment Percentages, by Type, 2021 (%)
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Global Opioid Induced Constipation (OIC) Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation (OIC) Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Opioid Induced Constipation (OIC) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation (OIC) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioid Induced Constipation (OIC) Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Opioid Induced Constipation (OIC) Drugs revenues share in global market, 2021 (%)
Key companies Opioid Induced Constipation (OIC) Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Opioid Induced Constipation (OIC) Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
1 Introduction to Research & Analysis Reports
1.1 Opioid Induced Constipation (OIC) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Induced Constipation (OIC) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Opioid Induced Constipation (OIC) Drugs Overall Market Size
2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size: 2021 VS 2028
2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Opioid Induced Constipation (OIC) Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Opioid Induced Constipation (OIC) Drugs Players in Global Market
3.2 Top Global Opioid Induced Constipation (OIC) Drugs Companies Ranked by Revenue
3.3 Global Opioid Induced Constipation (OIC) Drugs Revenue by Companies
3.4 Global Opioid Induced Constipation (OIC) Drugs Sales by Companies
3.5 Global Opioid Induced Constipation (OIC) Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Opioid Induced Constipation (OIC) Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioid Induced Constipation (OIC) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Opioid Induced Constipation (OIC) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Opioid Induced Constipation (OIC) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Opioid Induced Constipation (OIC) Drugs Market Size Markets, 2021 & 2028
4.1.2 Lubiprostone
4.1.3 Methyl Naltrexone Bromide
4.1.4 Naldemedine
4.1.5 Alvimopan
4.1.6 Others
4.2 By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue & Forecasts
4.2.1 By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2022
4.2.2 By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2023-2028
4.2.3 By Type - Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Opioid Induced Constipation (OIC) Drugs Sales & Forecasts
4.3.1 By Type - Global Opioid Induced Constipation (OIC) Drugs Sales, 2017-2022
4.3.2 By Type - Global Opioid Induced Constipation (OIC) Drugs Sales, 2023-2028
4.3.3 By Type - Global Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Opioid Induced Constipation (OIC) Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Opioid Induced Constipation (OIC) Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue & Forecasts
5.2.1 By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2022
5.2.2 By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2023-2028
5.2.3 By Application - Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Opioid Induced Constipation (OIC) Drugs Sales & Forecasts
5.3.1 By Application - Global Opioid Induced Constipation (OIC) Drugs Sales, 2017-2022
5.3.2 By Application - Global Opioid Induced Constipation (OIC) Drugs Sales, 2023-2028
5.3.3 By Application - Global Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Opioid Induced Constipation (OIC) Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Opioid Induced Constipation (OIC) Drugs Market Size, 2021 & 2028
6.2 By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue & Forecasts
6.2.1 By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2022
6.2.2 By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue, 2023-2028
6.2.3 By Region - Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Opioid Induced Constipation (OIC) Drugs Sales & Forecasts
6.3.1 By Region - Global Opioid Induced Constipation (OIC) Drugs Sales, 2017-2022
6.3.2 By Region - Global Opioid Induced Constipation (OIC) Drugs Sales, 2023-2028
6.3.3 By Region - Global Opioid Induced Constipation (OIC) Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.4.2 By Country - North America Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.4.3 US Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.4.4 Canada Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.4.5 Mexico Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.5.3 Germany Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.4 France Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.5 U.K. Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.6 Italy Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.7 Russia Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.5.9 Benelux Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.6.3 China Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6.4 Japan Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6.5 South Korea Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.6.7 India Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.7.2 By Country - South America Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.7.3 Brazil Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.7.4 Argentina Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales, 2017-2028
6.8.3 Turkey Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.8.4 Israel Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
6.8.6 UAE Opioid Induced Constipation (OIC) Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Ironwood Pharmaceuticals Inc
7.1.1 Ironwood Pharmaceuticals Inc Corporate Summary
7.1.2 Ironwood Pharmaceuticals Inc Business Overview
7.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Ironwood Pharmaceuticals Inc Key News
7.2 Daiichi Sankyo Co Ltd
7.2.1 Daiichi Sankyo Co Ltd Corporate Summary
7.2.2 Daiichi Sankyo Co Ltd Business Overview
7.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Daiichi Sankyo Co Ltd Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Progenics Pharmaceuticals Inc
7.4.1 Progenics Pharmaceuticals Inc Corporate Summary
7.4.2 Progenics Pharmaceuticals Inc Business Overview
7.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Progenics Pharmaceuticals Inc Key News
7.5 Shionogi & Co., Ltd
7.5.1 Shionogi & Co., Ltd Corporate Summary
7.5.2 Shionogi & Co., Ltd Business Overview
7.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Shionogi & Co., Ltd Key News
7.6 Allergan Plc
7.6.1 Allergan Plc Corporate Summary
7.6.2 Allergan Plc Business Overview
7.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Allergan Plc Key News
7.7 Nektar Therapeutics
7.7.1 Nektar Therapeutics Corporate Summary
7.7.2 Nektar Therapeutics Business Overview
7.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Nektar Therapeutics Key News
7.8 Purdue Pharma
7.8.1 Purdue Pharma Corporate Summary
7.8.2 Purdue Pharma Business Overview
7.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Purdue Pharma Key News
7.9 S.L.A. Pharma AG
7.9.1 S.L.A. Pharma AG Corporate Summary
7.9.2 S.L.A. Pharma AG Business Overview
7.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.9.5 S.L.A. Pharma AG Key News
7.10 Mundipharma International Limited
7.10.1 Mundipharma International Limited Corporate Summary
7.10.2 Mundipharma International Limited Business Overview
7.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Mundipharma International Limited Key News
7.11 Ono Pharmaceutical Co., Ltd
7.11.1 Ono Pharmaceutical Co., Ltd Corporate Summary
7.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Overview
7.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Ono Pharmaceutical Co., Ltd Key News
7.12 Takeda Pharmaceutical Company Limited
7.12.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Business Overview
7.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Takeda Pharmaceutical Company Limited Key News
7.13 Theravance Biopharma Inc
7.13.1 Theravance Biopharma Inc Corporate Summary
7.13.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Business Overview
7.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.13.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Theravance Biopharma Inc Key News
7.14 Bausch Health
7.14.1 Bausch Health Corporate Summary
7.14.2 Bausch Health Business Overview
7.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Bausch Health Key News
7.15 Cosmo Pharmaceuticals SA
7.15.1 Cosmo Pharmaceuticals SA Corporate Summary
7.15.2 Cosmo Pharmaceuticals SA Business Overview
7.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Cosmo Pharmaceuticals SA Key News
7.16 Daewoong Pharmaceutical
7.16.1 Daewoong Pharmaceutical Corporate Summary
7.16.2 Daewoong Pharmaceutical Business Overview
7.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Daewoong Pharmaceutical Key News
7.17 C.B. Fleet Company
7.17.1 C.B. Fleet Company Corporate Summary
7.17.2 C.B. Fleet Company Business Overview
7.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.17.5 C.B. Fleet Company Key News
7.18 Sucampo Pharmaceuticals
7.18.1 Sucampo Pharmaceuticals Corporate Summary
7.18.2 Sucampo Pharmaceuticals Business Overview
7.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Major Product Offerings
7.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Sucampo Pharmaceuticals Key News
8 Global Opioid Induced Constipation (OIC) Drugs Production Capacity, Analysis
8.1 Global Opioid Induced Constipation (OIC) Drugs Production Capacity, 2017-2028
8.2 Opioid Induced Constipation (OIC) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Opioid Induced Constipation (OIC) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Opioid Induced Constipation (OIC) Drugs Supply Chain Analysis
10.1 Opioid Induced Constipation (OIC) Drugs Industry Value Chain
10.2 Opioid Induced Constipation (OIC) Drugs Upstream Market
10.3 Opioid Induced Constipation (OIC) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Opioid Induced Constipation (OIC) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com